16168057

Source:http://linkedlifedata.com/resource/pubmed/id/16168057

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0034394, umls-concept:C0036525, umls-concept:C0038951, umls-concept:C0235032, umls-concept:C1522484, umls-concept:C1527249
pubmed:dateCreated	2005-10-25
pubmed:abstractText	New chemotherapy regimens for patients with colorectal cancer have improved survival, but at the cost of clinical toxicity. Oxaliplatin, an agent used in first-line therapy for metastatic colorectal cancer, causes acute and chronic neurotoxicity. This study was performed to carefully assess the incidence, type and duration of oxaliplatin neurotoxicity.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-10048138, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-10442188, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-10572615, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-10623704, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-10944126, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-11332158, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-11353042, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-11459999, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-11720843, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-11919232, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-11919233, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-11956262, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-12075739, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-12149316, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-12177109, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-12422305, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-12453338, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-12663719, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-12775730, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-12952569, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-12954576, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-14523789, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-14657227, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-14665611, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-14745869, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-14974761, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-14981738, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-15169795, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-15175436, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-15217938, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-15269607, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-15494638, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-7932825, http://linkedlifedata.com/resource/pubmed/commentcorrection/16168057-9626791
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100967800
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Organoplatinum Compounds, http://linkedlifedata.com/resource/pubmed/chemical/capecitabine, http://linkedlifedata.com/resource/pubmed/chemical/oxaliplatin
pubmed:status	MEDLINE
pubmed:issn	1471-2407
pubmed:author	pubmed-author:FioravantiSuzanneS, pubmed-author:GremJean LJL, pubmed-author:HaroldNancyN, pubmed-author:LeonardGregory DGD, pubmed-author:QuinnMary GMG, pubmed-author:SchulerBarbaraB, pubmed-author:ThomasRebecca RRR, pubmed-author:WrightMaurice AMA
pubmed:issnType	Electronic
pubmed:volume	5
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	116
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:16168057-Adult, pubmed-meshheading:16168057-Aged, pubmed-meshheading:16168057-Antimetabolites, Antineoplastic, pubmed-meshheading:16168057-Antineoplastic Agents, pubmed-meshheading:16168057-Clinical Trials as Topic, pubmed-meshheading:16168057-Colorectal Neoplasms, pubmed-meshheading:16168057-Deoxycytidine, pubmed-meshheading:16168057-Female, pubmed-meshheading:16168057-Fluorouracil, pubmed-meshheading:16168057-Humans, pubmed-meshheading:16168057-Male, pubmed-meshheading:16168057-Middle Aged, pubmed-meshheading:16168057-Neoplasm Metastasis, pubmed-meshheading:16168057-Neurotoxicity Syndromes, pubmed-meshheading:16168057-Organoplatinum Compounds, pubmed-meshheading:16168057-Paresthesia, pubmed-meshheading:16168057-Questionnaires, pubmed-meshheading:16168057-Time Factors, pubmed-meshheading:16168057-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.
pubmed:affiliation	Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Naval Medical Center, Bethesda, MD 20889-5105, USA. LeonardG@Sehb.ie
pubmed:publicationType	Journal Article, Clinical Trial, Phase I